Tumour stromal cells secrete proangiogenic and prometastatic factors, such as MMP3 and may support breast cancer progression through promotion of tumour angiogenesis and invasion
Potential Role of Monocyte Chemotactic Protein 1 (MCP-1) in the Breast Cancer...Marion Hartmann
MCP-1 has a potentially important role in the breast tumour microenvironment.
The results presented suggest it may exert its effect by promotion of tumour cell survival through up-regulation of anti-apoptotic factors and pro-migratory factors and thus may be a target for therapeutic intervention.
Cellular Signaling Pathways have direct implications on our understanding of tumor cell behavior. A general overview is presented here followed by a brief discussion of some of the major pathways currently implicated in cancer progression : Ras/RAF/MAP kinase pathway and PI3K/AKT/mTOR pathway s
Potential Role of Monocyte Chemotactic Protein 1 (MCP-1) in the Breast Cancer...Marion Hartmann
MCP-1 has a potentially important role in the breast tumour microenvironment.
The results presented suggest it may exert its effect by promotion of tumour cell survival through up-regulation of anti-apoptotic factors and pro-migratory factors and thus may be a target for therapeutic intervention.
Cellular Signaling Pathways have direct implications on our understanding of tumor cell behavior. A general overview is presented here followed by a brief discussion of some of the major pathways currently implicated in cancer progression : Ras/RAF/MAP kinase pathway and PI3K/AKT/mTOR pathway s
Hallmarks of cancer and radiopharmaceuticalsAlice Viana
In this presentation I review the article Hallmarks of cancer: next generation, from Hanahan and Weinberg, and make a parallel with potential and current targets of radiopharmaceuticals for diagnosis and treatment.
This slideshow gives all the basic information about Canine Mast Cell Tumor such as introduction to mast cells, mast cell tumor, diagnosis, grading of tumors, the immunohistochemistry of the tumors, treatment etc.
Canine oncoprotein targets for Melanoma, Breast Cancer, OsteosarcomaSnehal Salunkhe
We can acquire the basic knowledge about canine oncoprotein targets specifically for Melanoma, Osteosarcoma and Breast cancer. I haven't mentioned all the proteins and their targets involved, but just a general overview of these targets with the drugs involved in their treatment/clinical trials.
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...Marion Hartmann
This study demonstrates a novel correlation between CCL5 and TGFβ1 in breast cancer which is maintained in early and advanced disease
The mechanisms and controlling influences warrant further investigation and may open avenues for therapeutic manipulation in selected patients
Hallmarks of cancer and radiopharmaceuticalsAlice Viana
In this presentation I review the article Hallmarks of cancer: next generation, from Hanahan and Weinberg, and make a parallel with potential and current targets of radiopharmaceuticals for diagnosis and treatment.
This slideshow gives all the basic information about Canine Mast Cell Tumor such as introduction to mast cells, mast cell tumor, diagnosis, grading of tumors, the immunohistochemistry of the tumors, treatment etc.
Canine oncoprotein targets for Melanoma, Breast Cancer, OsteosarcomaSnehal Salunkhe
We can acquire the basic knowledge about canine oncoprotein targets specifically for Melanoma, Osteosarcoma and Breast cancer. I haven't mentioned all the proteins and their targets involved, but just a general overview of these targets with the drugs involved in their treatment/clinical trials.
Correlation between circulating and tumour tissue CCL5 and TGFβ1 in breast ca...Marion Hartmann
This study demonstrates a novel correlation between CCL5 and TGFβ1 in breast cancer which is maintained in early and advanced disease
The mechanisms and controlling influences warrant further investigation and may open avenues for therapeutic manipulation in selected patients
Claudin 1 expression in basal-like breast cancer is related to patient ageEnrique Moreno Gonzalez
Defects in tight junctions, gate-keepers of the integrity of the epidermal barrier function, are known to contribute to cancer development. As such, enhancing our understanding of how the expression of proteins involved in these junctions is regulated in cancer, remains a priority. Although the expression of one of these proteins, claudin 1, is down regulated in most invasive human breast cancers (HBC), we have recently shown that high levels of claudin 1, characterized tumors belonging to the very aggressive basal-like breast cancer (BLBC) subtype. In these tumors, the claudin 1.
Molecular Subtyping of Breast Cancer and Somatic Mutation Discovery Using DNA...Setia Pramana
Molecular Subtyping of Breast Cancer and Somatic Mutation Discovery Using DNA and RNA sequence
Guess Lecture at Computer Science Department, IPB, Bogor
Analysis of primary breast tumour stromal cells and their potential role in d...Marion Hartmann
Although malignant epithelial cells are the origin of breast cancer and the main focus of research, evidence is increasing that the tumour microenvironment plays an important role in disease progression. Cellular interactions within the breast cancer microenvironment promote tumour growth, invasion, metastasis and resistance to therapy. Breast tumour stroma consists of various cell types including immunocytes, pericytes, endothelial cells and carcinoma associated fibroblasts. Stromal cells are the predominant cell type in the tumour microenvironment. Tumour stromal cells actively secrete growth factors, chemokines and cytokines that support tumourigenesis. Although the tumour promoting effect of stromal-epithelial interactions is recognized, the precise mechanisms involved are poorly understood. Further characterisation of tumour stromal cells will facilitate elucidation of these interactions.
Macrophages as Targets in Cancer Immunotherapy - Creative BiolabsCreative-Biolabs
Due to the limitations and shortages of traditional cancer treatments, immunotherapy has become the most promising cancer treatment. Various cancer immunotherapy strategies have emerged. These include adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small molecule inhibitors. Although most of these strategies are not meant to target macrophages directly or originally, macrophages contribute significantly to the final outcomes.
As a CRO company, Creative Biolabs offers first-in-class macrophage therapeutic development services. Please don’t hesitate to contact us if you are interested in our services or if you have any questions.
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3ryE5ST
Optimize your mesenchymal stem cell growth. Join our webinar to learn more about our GMP-compliant xeno free media formulation that supports high performance expansions and compatibility with scalable xeno free manufacturing conditions.
Optimizing ex vivo cell expansion processes in preparation for clinical use is a critical step in cell therapy manufacturing. Given the curative and lifesaving impacts these therapies can have on patients, overcoming roadblocks with scalability and supply chain, using high quality raw materials are essential for therapeutic access.
The GMP-compliant Stemline® XF MSC Medium and cocktail promotes expansion of human mesenchymal stromal/stem cells (hMSCs) to high densities while maintaining cell identity and quality. This product was designed for derivation and expansion of MSCs using xeno free conditions in planar and microcarrier-based culture platforms, easing the transfer between research, clinical, and manufacturing scale cultures.
In this webinar, you will:
• Explore the current landscape and future trends of cell culture media for adult mesenchymal stem cells
• Discover ways to derive MSC's from Bone Marrow in Xeno Free conditions from static to microcarrier-based suspension culture platforms.
• Learn how Stemline® XF MSC Media provides robust performance and reduces scalability roadblocks
Presented by: Kathleen Ongena, Ph.D., Head of Customer Applications and Mark Ventresco, Cell Therapy Product Manager
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...MilliporeSigma
Watch the presentation of this webinar here: https://bit.ly/3ryE5ST
Optimize your mesenchymal stem cell growth. Join our webinar to learn more about our GMP-compliant xeno free media formulation that supports high performance expansions and compatibility with scalable xeno free manufacturing conditions.
Optimizing ex vivo cell expansion processes in preparation for clinical use is a critical step in cell therapy manufacturing. Given the curative and lifesaving impacts these therapies can have on patients, overcoming roadblocks with scalability and supply chain, using high quality raw materials are essential for therapeutic access.
The GMP-compliant Stemline® XF MSC Medium and cocktail promotes expansion of human mesenchymal stromal/stem cells (hMSCs) to high densities while maintaining cell identity and quality. This product was designed for derivation and expansion of MSCs using xeno free conditions in planar and microcarrier-based culture platforms, easing the transfer between research, clinical, and manufacturing scale cultures.
In this webinar, you will:
• Explore the current landscape and future trends of cell culture media for adult mesenchymal stem cells
• Discover ways to derive MSC's from Bone Marrow in Xeno Free conditions from static to microcarrier-based suspension culture platforms.
• Learn how Stemline® XF MSC Media provides robust performance and reduces scalability roadblocks
Presented by: Kathleen Ongena, Ph.D., Head of Customer Applications and Mark Ventresco, Cell Therapy Product Manager
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Gene expression signature of primary breast tumour stromal cells
1. Gene expression signature of
primary breast tumour stromal
cells
MC Hartmann, RM Dwyer and MJ Kerin
Department of Surgery, National University of Ireland, Galway
2. Breast cancer microenvironment
• The importance of the breast cancer microenvironment in tumour progression is well
recognized
• Breast tumour stroma consists of various cell types such as immunocytes, pericytes
and fibroblasts
• Cellular interactions within the breast cancer microenvironment promote tumour
growth, invasion, metastasis and resistance to therapy
Lorusso et al, Histochem Cell Biol (2008)
CAF: carcinoma associated fibroblasts
ECM: extracellular matrix
TC: tumour cell
BMDC: bone marrow derived cell
PC: pericyte
MSC: mesenchymal stem cell
LV: lymphatic vessel
3. • Stromal cells are the predominant cell type within the tumour microenvironment
• Stromal-epithelial cell cross talk facilitated by paracrine factors and direct cell-cell
contact
• Tumour stromal cells are actively secreting factors (growth factors, chemokines,
cytokines) supporting tumourigenesis
Stromal cellTumour cell
Tumour stromal-epithelial interaction
GF
ECM
CK
The stromal-epithelial interaction in the
tumour microenvironment
GF : Growth factors
ECM : Extracellular matrix
CK: Cytokines
4. Aim
Characterise stromal cells derived from primary breast
tumours and potentially elucidate mechanisms through
which they exert their actions
6. Analysis of gene expression
Primary stromal cells isolated,
cultured and harvested
RNA Extraction
Targets of interest
•Vascular endothelial growth factor (VEGF)
• Matrix metalloproteinase 3 (MMP3)
• Transforming growth factor beta 1 (TGFβ1)
• Transforming growth factor beta receptor 2 (TGFβ R2)
•Fibroblast activation protein (FAP)
cDNA synthesis
Real time
quantitative PCR
7. MMP3 expression in stromal cells
Tan StroTum StroNorm Stro
5
4
3
2
1
Log10relativeMMP3expression
MMP3 expr ession in str omal cells
N=4 N=24 N=12
8. FAP, VEGF, TGFβ1, TGFβR2 expression in stromal
cells
Tan StroTum StroNorm Stro
20
15
10
5
0
relativeFAPexpression
FAP expression in stromal cells
Tan StroTum StroNorm Stro
16
14
12
10
8
6
4
2
0
RelativeVEGFexpression
VEGF expression in stromal cells
Tan stroTum StroNorm stro
12
10
8
6
4
2
0
RelativeTGFb1expression
TGFb1 expression in stromal cells
Tan StroTum StroNorm Stro
35
30
25
20
15
10
5
0
TGFbR2expressionlevel
TGFbR2 expression in stromal cells
9. Correlation of TGFβ 1 and TGFβ R2 expression
Correlation of TGFβ1 and TGFβ R2
0
2
4
6
8
10
12
14
16
18
Primary stromal cells n=40
RelativeTGFβ1and
TGFβR2expressionlevel
TGFβ1
TGFβR2
R=0.65 P<0.01
10. Correlation of VEGF and MMP3 expression
Correlation of VEGF and MMP3
0
2
4
6
8
10
12
14
16
18
Primary stromal cells n=40
RelativelevelofVEGFand
MMP3expression
MMP3
VEGF
R=0.29 P<0.05
11. Correlation of FAP and TGFβR2 expression
Correlation of FAP and TGFβR2
0
5
10
15
20
25
30
35
Primary stromal cells n=40
RelativelevelofFAPandTGFβR2
FAP
TGFBR2
R=0.28 P<0.05
12. Summary
• Trend towards increased expression of MMP3 in tumour
compared to normal stromal cells
• Significant positive Pearson correlation found between
• TGFβ1 and TGFβR2
• MMP3 and VEGF
• FAP and TGFβR2
13. Conclusion
Tumour stromal cells secrete proangiogenic and
prometastatic factors, such as MMP3 and may support
breast cancer progression through promotion of tumour
angiogenesis and invasion
Editor's Notes
Fig. 1 Heterotypic cellular interactions in the tumor microenvironment.
a Tumor cells orchestrate directly (e.g. though the release of factors)
or indirectly (though the induction of tissue hypoxia or
appearance of necrosis) the modiWcation of the microenvironment by
attracting or activating many non-tumoral cells, including blood and
lymphatic endothelial cells and pericytes, carcinoma associated Wbroblast,
bone marrow-derived cells, immune and inXammatory cells. Tumor
cells can also deposit or modify the extracellular matrix. Most of
these stromal modiWcations start early during tumor progression, often
at the transition stage from premalignant to malignant lesions. In some
cases they may even precede cancer formation, for example
in situations of chronic inXammatory conditions. b In turn, tumor
microenvironmental events promote tumor progression by stimulating
tumor growth and survival, and facilitating invasion and metastasis.
Collectively these events will contribute to determine the outcome of
tumor progression: tumor growth, tumor dormancy, tumor invasion
and metastasis and resistance to therapy. Abbreviations: B B lymphocyte;
BMDC bone marrow-derived cells; BV blood vessel; CAF carcinoma
associated Wbroblast; EC endothelial cell; ECM extracellular
matrix; EMT epithelial to mesenchymal transition; Gr granulocyte;
LEC lymphatic endothelial cell; LV lymphatic vessel; Mo monocyte;
MSC mesenchymal stem cell; PC pericyte; T T lymphocyte; TAM tumor
associated monocyte/macrophage; TC tumor cells